One Electron Reduction of Vanadate(V) to Oxovanadium(IV) by Low-Molecular-Weight Biocomponents Like Saccharides and Ascorbic Acid: Effect of Oxovanadium(IV) Complexes on pUC18 DNA and on Lipid Peroxidation in Isolated Rat Hepatocytes

1996 ◽  
Vol 224 (1) ◽  
pp. 115-120 ◽  
Author(s):  
Alavattam Sreedhara ◽  
Nobuyuki Susa ◽  
Anjali Patwardhan ◽  
Chebrolu P. Rao
2001 ◽  
Vol 129 (5) ◽  
pp. 683-689 ◽  
Author(s):  
A. Hino ◽  
M. Morita ◽  
M. Une ◽  
K. Fujimura ◽  
T. Kuramoto

2013 ◽  
Vol 91 (1) ◽  
pp. 56-63 ◽  
Author(s):  
Stephanie L. MacAllister ◽  
Cheryl Young ◽  
Anna Guzdek ◽  
Nickholas Zhidkov ◽  
Peter J. O'Brien

Chlorpromazine (CPZ), a member of the largest class of first-generation antipsychotic agents, is known to cause hepatotoxicity in the form of cholestasis and hepatocellular necrosis in some patients. The mechanism of CPZ hepatotoxicity is unclear, but is thought to result from reactive metabolite formation. The goal of this research was to assess potential cytotoxic mechanisms of CPZ using the accelerated cytotoxicity mechanism screening (ACMS) technique with freshly isolated rat hepatocytes. This study identified CPZ cytotoxicity and inhibition of mitochondrial membrane potential (MMP) to be concentration-dependent. Furthermore, inhibition of cytochrome P450s (CYPs), including CYP2D1 and 1A2, delayed CPZ cytotoxicity, suggesting a role for CYP activation of CPZ to a toxic metabolite(s) in this model. Metabolism studies also demonstrated glucuronide and glutathione (GSH) requirement for CPZ detoxification in hepatocytes. Inactivating the 2-electron reduction pathway, NAD(P)H quinone oxidoreductase (NQO1), caused a significant increase in hepatocyte susceptibility to CPZ, indicating quinoneimine contribution to CPZ cytotoxicity. Nontoxic concentrations of peroxidase/H2O2 (inflammatory model) increased cytotoxicity in CPZ-treated hepatocytes and caused additional mitochondrial toxicity. Inflammation further depleted GSH and increased oxidized glutathione (GSSG) levels. Results suggest activation of CPZ to reactive metabolites by 2 pathways in hepatocytes: (i) a CYP-catalyzed quinoneimine pathway, and (ii) a peroxidase-catalyzed oxidation of CPZ to CPZ radicals.


1982 ◽  
Vol 49 (3-4) ◽  
pp. 265-273 ◽  
Author(s):  
N. de Ruiter ◽  
H. Ottenwälder ◽  
H. Muliawan ◽  
H. Kappus

1989 ◽  
Vol 25 (1) ◽  
pp. 55-62 ◽  
Author(s):  
Ronald J Sokol ◽  
Michael W Devereaux ◽  
Maret G Traber ◽  
Robert H Shikes

Sign in / Sign up

Export Citation Format

Share Document